{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:52:28Z","timestamp":1782993148739,"version":"3.54.5"},"reference-count":5,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2024,6,12]]},"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1136\/jnnp-2024-333920","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:21:08Z","timestamp":1720113668000},"page":"1095-1095","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Cyclophosphamide for myasthenia gravis: a comeback?"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5546-0221","authenticated-orcid":false,"given":"Carolina","family":"Barnett-Tapia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D","family":"Katzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"2024111803350648000_95.12.1095.1","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1212\/WNL.0000000000012604","article-title":"Patient-reported symptom severity in a nationwide myasthenia gravis cohort: cross-sectional analysis of the Swedish GEMG study","volume":"97","author":"Petersson","year":"2021","journal-title":"Neurology"},{"key":"2024111803350648000_95.12.1095.2","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.119"},{"key":"2024111803350648000_95.12.1095.3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp-2023-333189","article-title":"Induction cyclophosphamide with maintenance Immuno suppression in high-risk myasthenia gravis:long-term follow-up and safety profile","volume":"95","author":"Chan","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024111803350648000_95.12.1095.4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.2887"},{"key":"2024111803350648000_95.12.1095.5","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1212\/WNL.0000000000013121","article-title":"Phase 2 trial of Rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis: the Beatmg study","volume":"98","author":"Nowak","year":"2022","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2024-333920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:08:17Z","timestamp":1732367297000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2024-333920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,11,18]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/jnnp-2024-333920"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2024-333920","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]}}}